Boston Children’s Hospital


Disulfiram: Could this be Repurposed to Target An Over-Active Immune System Associated with the COVID-19 Cytokine Storm?

Researchers from Harvard Medical School and Boston Children’s Hospital reveal that the FDA-approved drug disulfiram, often used to treat alcoholism, blocks a key gatekeeper protein contributing to inflammation. COVID-19 kills not because of the virus itself, but...

Pin It on Pinterest